.png){kind=icon}
Return
Multiple sclerosis
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(18)30481-1.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Multiple sclerosis continues to be a challenging and disabling condition but there is now greater understanding of the underlying genetic and environmental factors that drive the condition, including low vitamin D levels, cigarette smoking, and obesity. Early and accurate diagnosis is crucial and is supported by diagnostic criteria, incorporating imaging and spinal fluid abnormalities for those presenting with a clinically isolated syndrome. Importantly, there is an extensive therapeutic armamentarium, both oral and by infusion, for those with the relapsing remitting form of the disease. Careful consideration is required when choosing the correct treatment, balancing the side-effect profile with efficacy and escalating as clinically appropriate. This move towards more personalised medicine is supported by a clinical guideline published in 2018. Finally, a comprehensive management programme is strongly recommended for all patients with multiple sclerosis, enhancing health-related quality of life through advocating wellness, addressing aggravating factors, and managing comorbidities. The greatest remaining challenge for multiple sclerosis is the development of treatments incorporating neuroprotection and remyelination to treat and ultimately prevent the disabling, progressive forms of the condition.
Keywords:
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
MAGNIMS CONSENSUS GUIDELINES
CLINICALLY ISOLATED SYNDROME
GENETIC RISK BURDEN
DOUBLE-BLIND
FOLLOW-UP
PHARMACOLOGICAL MANAGEMENT
RETROSPECTIVE ANALYSIS
COGNITIVE IMPAIRMENT
CONTROLLED-TRIAL
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
88.5
Papers:
5.4W
Citations:
34.8W
Organization
Cited Papers
ShareSaveThe application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis - Identification and characterization of the primary demyelinating lesion.png)
BRAIN
OAAI
BRAINIF11.7
OAAIShareSaveShareSaveEffects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trialOAAI
OAAIShareSaveMAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic processNATURE REVIEWS NEUROLOGYOAAI
NATURE REVIEWS NEUROLOGYIF33.1
OAAIShareSaveShareSave
View more